Lee Ainslie - Maverick Capital
Holding/activity history for TG Therapeutics, Inc. (TGTX)
← All TGTX superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2023 Q1 | 0 | 0.00 | Sell 100.00% | 1.20 | $10.00–19.59 · VW $15.06i | SEC | |
| 2022 Q4 | 4,318,700 | 1.20 | Reduce 43.93% | 0.46 | $4.86–11.88 · VW $8.87i | $51,090,221 | SEC |
| 2022 Q3 | 7,701,870 | 1.04 | Add 14.14% | 0.13 | $4.22–8.65 · VW $6.46i | $45,595,000 | SEC |
| 2022 Q2 | 6,747,549 | 0.71 | Add 1.05% | <0.01 | $3.48–10.87 · VW $5.71i | $28,677,000 | SEC |
| 2022 Q1 | 6,677,726 | 1.15 | Add 10.65% | 0.11 | $7.73–20.69 · VW $11.31i | $63,505,000 | SEC |
| 2021 Q4 | 6,034,875 | 1.30 | Add 83.07% | 0.59 | $12.62–35.94 · VW $21.38i | $114,663,000 | SEC |
| 2021 Q3 | 3,296,451 | 1.11 | Add 16.85% | 0.16 | $21.06–41.00 · VW $29.69i | $109,706,000 | SEC |
| 2021 Q2 | 2,821,079 | 1.04 | Reduce 5.05% | 0.07 | $32.30–50.00 · VW $40.07i | $109,430,000 | SEC |
| 2021 Q1 | 2,971,136 | 1.31 | Reduce 7.21% | 0.19 | $38.44–56.74 · VW $47.91i | $143,209,000 | SEC |
| 2020 Q4 | 3,202,061 | 2.67 | Reduce 27.10% | 0.59 | $24.93–56.11 · VW $37.02i | $166,571,000 | SEC |
| 2020 Q3 | 4,392,196 | 2.18 | Add 3277.60% | 2.12 | $17.67–27.62 · VW $23.27i | $117,535,000 | SEC |
| 2020 Q2 | 130,039 | 0.05 | Buy | 0.05 | $8.75–22.28 · VW $16.33i | $2,533,000 | SEC |
Price snapshot:
Current price$55.01
52-week low$25.28
52-week high$59.30